ITGAX and neoplasm: We observed that ESCC patients with positive TLSs tended to be surrounded by more CD45+ leukocytes, as well as a higher number of tumor‐infiltrating CD4+ T cells, CD8+ T cells CD20+ B cells, and CD11c+ DCs.